A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
NCT01761019
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Taclonex Topical Suspension
Sponsor
University of Pittsburgh
Collaborators
[object Object]